FTSE All-Share
|
5 220,97
|
-56,68
|
-1,07 %
|
Analysen zu FTSE All-Share-Werten
| 29.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 28.11.23 | Glencore Outperform | RBC Capital Markets | |
| 28.11.23 | GSK Buy | Deutsche Bank AG | |
| 27.11.23 | Unilever Overweight | Barclays Capital | |
| 27.11.23 | HSBC Holdings Neutral | UBS AG | |
| 27.11.23 | BP Outperform | RBC Capital Markets | |
| 27.11.23 | Rio Tinto Neutral | UBS AG | |
| 27.11.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.11.23 | Vodafone Group Buy | UBS AG | |
| 23.11.23 | BAT Sector Perform | RBC Capital Markets | |
| 23.11.23 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 22.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 22.11.23 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 21.11.23 | National Grid Overweight | JP Morgan Chase & Co. | |
| 20.11.23 | AstraZeneca Overweight | Barclays Capital | |
| 20.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 17.11.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 17.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 16.11.23 | Burberry Sell | UBS AG | |
| 16.11.23 | Diageo Neutral | Goldman Sachs Group Inc. |